We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

17 hedge funds and large institutions have $61.3K invested in Coeptis Therapeutics Warrants in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0.75% less ownership

Funds ownership: 6.41% → 5.67% (-0.75%)

4% less capital invested

Capital invested by funds: $63.8K → $61.3K (-$2.54K)

15% less funds holding

Funds holding: 20 → 17 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$123
2
Citadel Advisors
Citadel Advisors
Florida
+$3
3
Bank of America
Bank of America
North Carolina
+$1

Top Sellers

Rank Fund Capital Flow
1
SM
Skaana Management
New York
-$744
2
TSS
Two Sigma Securities
New York
-$358
3
WAM
Wolverine Asset Management
Illinois
-$141
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
1
Meteora Capital
Florida
$27K – – –
CF
2
Cantor Fitzgerald
New York
$12.8K – – –
RCM
3
Rivernorth Capital Management
Florida
$4.5K – – –
Walleye Capital
4
Walleye Capital
New York
$3.27K – – –
CL
5
CSS LLC
Illinois
$2.32K – – –
Walleye Trading
6
Walleye Trading
New York
$2.18K – – –
ICM
7
Ionic Capital Management
New York
$2.11K – – –
HF
8
HRT Financial
New York
$2K – – –
CAC
9
Cowen and Company
New York
$1.36K – – –
SIA
10
SkyView Investment Advisors
New Jersey
$1K – – –
LCM
11
Landscape Capital Management
New Jersey
$961 – – –
WAM
12
Wolverine Asset Management
Illinois
$836 -$141 -5,618 -17%
HHGC
13
Hunting Hill Global Capital
New York
$491 – – –
Citadel Advisors
14
Citadel Advisors
Florida
$346 +$3 +100 +0.9%
UBS Group
15
UBS Group
Switzerland
$75 +$123 +4,900 +5,632%
CS
16
Clear Street
New York
$63 – – –
Bank of America
17
Bank of America
North Carolina
$10 +$1 +38 +6%
SM
18
Skaana Management
New York
– -$744 -29,180 Closed
TSS
19
Two Sigma Securities
New York
– -$358 -14,026 Closed

COEPW Hedge Fund Activity: Q2 2024 in Review

17 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2024, worth a combined $61.3K — down 4% from $63.8K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of COEPW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was UBS Group, adding an estimated $123. The largest seller was Skaana Management, exiting entirely with an estimated $744 sold.

  • 17 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2024, down from 20 in Q1 2024.
  • Funds reported $61.3K of Coeptis Therapeutics Warrants stock for Q2 2024, down 4% quarter-over-quarter.
  • 0 funds opened new Coeptis Therapeutics Warrants positions in Q2 2024 and 2 closed out, a net change of -2 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q2 2024 was UBS Group, an estimated $123 added.
  • The largest Coeptis Therapeutics Warrants seller in Q2 2024 was Skaana Management, an estimated $744 sold.

Based on aggregated 13F filings for Q2 2024.